Insights

Acquisition Opportunity Trials.ai appears to be a small, AI-driven clinical trial design firm that was acquired by ZS Associates in February 2023. This acquisition could open cross-sell opportunities for ZS in its broader pharmaceutical and life sciences consulting services, as well as potential integration of AI-enabled study design capabilities into larger client engagements.

AI Protocol Advantage The company focuses on AI-enabled trial design and Smart Protocol solutions, offering a differentiated value proposition for sponsors seeking faster go-to-market timelines. This positions them to upsell enhanced study design optimization and analytics services to mid-to-large pharma and biopharma clients.

Early Stage Capital With modest funding of around $1.3M and revenue under $1M, there is a clear opportunity to propose scalable, enterprise-grade deployment, FIR (financially independent) productization, and partnerships that can accelerate revenue growth while expanding customer proof points.

Technology Alignment Tech stack leverages cloud and web technologies (AWS, S3, PHP, WordPress, jQuery) suitable for integration with enterprise data platforms. This could enable joint offerings around data integration, trial workflow automation, and compliant analytics for pharmaceutical clients.

Market Positioning As a niche AI-enabled trial design solution with a recent acquisition by a large analytics firm, there is a sales angle to position Trials.ai within broader digital health and life sciences transformation initiatives, targeting pharma companies pursuing efficiency gains, faster trial cycles, and AI-driven protocol optimization.

Similar companies to Trials.ai by ZS

Trials.ai by ZS Tech Stack

Trials.ai by ZS uses 8 technology products and services including Google PageSpeed, Amazon Web Services, Amazon S3, and more. Explore Trials.ai by ZS's tech stack below.

  • Google PageSpeed
    Caching
  • Cloud Hosting
  • Amazon S3
    Content Delivery Network
  • Content Management System
  • jQuery
    Javascript Libraries
  • Marketing Automation
  • PHP
    Programming Languages
  • System Analytics & Monitoring

Trials.ai by ZS's Email Address Formats

Trials.ai by ZS uses at least 3 email formats:
Trials.ai by ZS Email FormatsExamplePercentage
First@trials.aiJohn@trials.ai
50%
Last@trials.aiDoe@trials.ai
33%
First.Last@trials.aiJohn.Doe@trials.ai
17%

Frequently Asked Questions

What is Trials.ai by ZS's official website and social media links?

Minus sign iconPlus sign icon
Trials.ai by ZS's official website is trials.ai and has social profiles on LinkedIn and Crunchbase.

How much revenue does Trials.ai by ZS generate?

Minus sign iconPlus sign icon
As of October 2026, Trials.ai by ZS's annual revenue is estimated to be <$1M.

What is Trials.ai by ZS's NAICS code?

Minus sign iconPlus sign icon
Trials.ai by ZS's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does Trials.ai by ZS have currently?

Minus sign iconPlus sign icon
As of October 2026, Trials.ai by ZS has approximately 4 employees across 2 continents, including North America and South America. Key team members include Owner: E. T. and Senior Machine Learning Engineer: J. M. Explore Trials.ai by ZS's employee directory with LeadIQ.

What industry does Trials.ai by ZS belong to?

Minus sign iconPlus sign icon
Trials.ai by ZS operates in the Technology, Information and Internet industry.

What technology does Trials.ai by ZS use?

Minus sign iconPlus sign icon
Trials.ai by ZS's tech stack includes Google PageSpeed, Amazon Web Services, Amazon S3, WordPress, jQuery, HubSpot, PHP and Piwik.

What is Trials.ai by ZS's email format?

Minus sign iconPlus sign icon
Trials.ai by ZS's email format typically follows the pattern of First@trials.ai. Find more Trials.ai by ZS email formats with LeadIQ.

How much funding has Trials.ai by ZS raised to date?

Minus sign iconPlus sign icon
As of October 2026, Trials.ai by ZS has raised $1.3M in funding. The last funding round occurred on Jan 21, 2021.

When was Trials.ai by ZS founded?

Minus sign iconPlus sign icon
Trials.ai by ZS was founded in 2016.
Trials.ai by ZS logo

Trials.ai by ZS

Technology, Information and InternetNew Jersey, United States2-10 Employees

Trials.ai by ZS is a technology company based in Princeton, New Jersey, that concentrates on clinical trial design. It offers AI-enabled tools to help research teams plan and refine trial protocols, aiming to improve efficiency and speed in bringing pharmaceuticals to market. The approach centers on reducing the burden on patients by enabling faster, better-designed trials.

The company serves teams involved in clinical research, including pharmaceutical and biotech organizations seeking to optimize study design. In February 2023, ZS Associates announced it would acquire Trials.ai, indicating an integration with a global management consulting and technology firm.

Section iconCompany Overview

Website
trials.ai
NAICS Code
5415 - Computer Systems Design and Related Services
Founded
2016
Employees
2-10

Section iconFunding & Financials

  • $1.3M

    Trials.ai by ZS has raised a total of $1.3M of funding over 6 rounds. Their latest funding round was raised on Jan 21, 2021 as a Venture Round.

  • <$1M

    Trials.ai by ZS's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.